Inulin
CAS 9005-80-5
Inulin (CAS 9005-80-5) is a pharmaceutical compound with 0 bioactivity targets and 29 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Pneumonia aspiration | 36 | 152.452 | 10035669 |
| Coma | 36 | 138.53 | 10010071 |
| Gastrooesophageal reflux disease | 37 | 136.984 | 10017885 |
| Somnolence | 36 | 104.332 | 10041349 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| INULIN | 5924 | SU | MTHSPL |
| inulin | 5924 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Inulin used for in pharmaceutical contexts?
Inulin (CAS 9005-80-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Inulin?
Inulin has 29 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Pneumonia aspiration, Coma, Gastrooesophageal reflux disease, Somnolence, Aphthous ulcer. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Inulin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Prebiotic Inulin with EU status "permitted".
What clinical phase is Inulin in?
No phase 1-4 clinical development badge is rendered for Inulin because the matched compound identifier rows do not contain a max-phase value.